Thermo Fisher Scientific’s (TMO) Outperform Rating Reaffirmed at Robert W. Baird
Thermo Fisher Scientific (NYSE:TMO – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Robert W. Baird in a research report issued on Thursday, Benzinga reports. They currently have a $670.00 price target on the medical research company’s stock. Robert W. Baird’s target price would indicate a potential upside of […]
More Stories
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...